

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of prostaglandin secretion (GO:0032308) | 9.06840936 |
| 2 | regulation of prostaglandin secretion (GO:0032306) | 7.96694059 |
| 3 | replicative senescence (GO:0090399) | 7.43262614 |
| 4 | negative regulation of catenin import into nucleus (GO:0035414) | 6.75579295 |
| 5 | regulation of endothelial cell differentiation (GO:0045601) | 6.07276529 |
| 6 | hematopoietic stem cell proliferation (GO:0071425) | 5.74470835 |
| 7 | DNA replication-dependent nucleosome assembly (GO:0006335) | 5.69555205 |
| 8 | DNA replication-dependent nucleosome organization (GO:0034723) | 5.69555205 |
| 9 | regulation of somitogenesis (GO:0014807) | 5.67821317 |
| 10 | positive regulation of icosanoid secretion (GO:0032305) | 5.67266959 |
| 11 | positive regulation of digestive system process (GO:0060456) | 5.59974928 |
| 12 | positive regulation of fatty acid transport (GO:2000193) | 5.57259739 |
| 13 | regulation of cardiac muscle cell contraction (GO:0086004) | 5.47712097 |
| 14 | detection of calcium ion (GO:0005513) | 5.22470466 |
| 15 | epithelial cell differentiation involved in kidney development (GO:0035850) | 5.20704483 |
| 16 | tryptophan metabolic process (GO:0006568) | 5.17882700 |
| 17 | positive regulation of cAMP-mediated signaling (GO:0043950) | 5.11861331 |
| 18 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 5.01288357 |
| 19 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.68427932 |
| 20 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 4.64604958 |
| 21 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 4.64604958 |
| 22 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.62128013 |
| 23 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 4.61799937 |
| 24 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 4.49319524 |
| 25 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 4.44882100 |
| 26 | release of cytochrome c from mitochondria (GO:0001836) | 4.43411584 |
| 27 | negative regulation of systemic arterial blood pressure (GO:0003085) | 4.33601273 |
| 28 | negative regulation of multicellular organism growth (GO:0040015) | 4.27082207 |
| 29 | primary amino compound metabolic process (GO:1901160) | 4.23222533 |
| 30 | neuronal action potential (GO:0019228) | 4.21629363 |
| 31 | indolalkylamine metabolic process (GO:0006586) | 4.18059821 |
| 32 | regulation of icosanoid secretion (GO:0032303) | 4.17770731 |
| 33 | regulation of actin filament-based movement (GO:1903115) | 4.08731799 |
| 34 | adrenergic receptor signaling pathway (GO:0071875) | 4.07404484 |
| 35 | serotonin metabolic process (GO:0042428) | 3.93552390 |
| 36 | cellular response to cholesterol (GO:0071397) | 3.78362165 |
| 37 | nucleobase catabolic process (GO:0046113) | 3.76071381 |
| 38 | negative regulation of peptidyl-lysine acetylation (GO:2000757) | 3.73848167 |
| 39 | acrosome reaction (GO:0007340) | 3.68938052 |
| 40 | positive regulation of organic acid transport (GO:0032892) | 3.51825055 |
| 41 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.51200094 |
| 42 | cellular response to sterol (GO:0036315) | 3.41018857 |
| 43 | DNA integration (GO:0015074) | 3.40756887 |
| 44 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.39899074 |
| 45 | NADH dehydrogenase complex assembly (GO:0010257) | 3.39899074 |
| 46 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.39899074 |
| 47 | axonal fasciculation (GO:0007413) | 3.32727326 |
| 48 | indole-containing compound catabolic process (GO:0042436) | 3.28038376 |
| 49 | indolalkylamine catabolic process (GO:0046218) | 3.28038376 |
| 50 | tryptophan catabolic process (GO:0006569) | 3.28038376 |
| 51 | negative regulation of mast cell activation (GO:0033004) | 3.26007770 |
| 52 | positive regulation of muscle hypertrophy (GO:0014742) | 3.24478215 |
| 53 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 3.24478215 |
| 54 | presynaptic membrane organization (GO:0097090) | 3.17759434 |
| 55 | tyrosine metabolic process (GO:0006570) | 3.16754706 |
| 56 | heparin metabolic process (GO:0030202) | 3.13569434 |
| 57 | heparin biosynthetic process (GO:0030210) | 3.13569434 |
| 58 | glycoprotein biosynthetic process (GO:0009101) | 3.13543219 |
| 59 | cardiac muscle adaptation (GO:0014887) | 3.12594713 |
| 60 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.12594713 |
| 61 | muscle hypertrophy in response to stress (GO:0003299) | 3.12594713 |
| 62 | indole-containing compound metabolic process (GO:0042430) | 3.11761157 |
| 63 | negative regulation of protein acetylation (GO:1901984) | 3.10463769 |
| 64 | presynaptic membrane assembly (GO:0097105) | 3.10375284 |
| 65 | postsynaptic membrane organization (GO:0001941) | 3.01239119 |
| 66 | positive regulation of heart rate (GO:0010460) | 3.00570855 |
| 67 | positive regulation of mitochondrial fission (GO:0090141) | 2.93253436 |
| 68 | C4-dicarboxylate transport (GO:0015740) | 2.92630604 |
| 69 | kynurenine metabolic process (GO:0070189) | 2.91439054 |
| 70 | response to auditory stimulus (GO:0010996) | 2.89482998 |
| 71 | regulation of cAMP-mediated signaling (GO:0043949) | 2.88242421 |
| 72 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193) | 2.87114621 |
| 73 | regulation of fatty acid transport (GO:2000191) | 2.79616559 |
| 74 | histone H2A monoubiquitination (GO:0035518) | 2.78206956 |
| 75 | behavioral response to nicotine (GO:0035095) | 2.76492164 |
| 76 | cytidine metabolic process (GO:0046087) | 2.72686785 |
| 77 | cytidine catabolic process (GO:0006216) | 2.72686785 |
| 78 | cytidine deamination (GO:0009972) | 2.72686785 |
| 79 | negative regulation of smooth muscle contraction (GO:0045986) | 2.71138998 |
| 80 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.69922837 |
| 81 | protein complex biogenesis (GO:0070271) | 2.69137997 |
| 82 | neuron recognition (GO:0008038) | 2.68686438 |
| 83 | auditory behavior (GO:0031223) | 2.68141416 |
| 84 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.66835691 |
| 85 | negative regulation of gene silencing (GO:0060969) | 2.62822171 |
| 86 | molting cycle (GO:0042303) | 2.62456984 |
| 87 | hair cycle (GO:0042633) | 2.62456984 |
| 88 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.60721005 |
| 89 | fear response (GO:0042596) | 2.58774123 |
| 90 | post-anal tail morphogenesis (GO:0036342) | 2.58702586 |
| 91 | positive regulation of cation channel activity (GO:2001259) | 2.57413302 |
| 92 | cell differentiation involved in kidney development (GO:0061005) | 2.57292288 |
| 93 | regulation of metalloenzyme activity (GO:0048552) | 2.55485711 |
| 94 | dendritic spine morphogenesis (GO:0060997) | 2.52579345 |
| 95 | neuron cell-cell adhesion (GO:0007158) | 2.51413884 |
| 96 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 2.51091959 |
| 97 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 2.51039445 |
| 98 | regulation of cardiac muscle cell differentiation (GO:2000725) | 2.50530426 |
| 99 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.49722378 |
| 100 | sensory perception of pain (GO:0019233) | 2.48162855 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 6.22410721 |
| 2 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 5.27548134 |
| 3 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.05297554 |
| 4 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.60771104 |
| 5 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.55548800 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.52180161 |
| 7 | TP53_16413492_ChIP-PET_HCT116_Human | 2.29674052 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.21830342 |
| 9 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.08078966 |
| 10 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.05100846 |
| 11 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 13.2379618 |
| 12 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.77072996 |
| 13 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.76992095 |
| 14 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.72591673 |
| 15 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.68930115 |
| 16 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.67000799 |
| 17 | VDR_22108803_ChIP-Seq_LS180_Human | 1.65159060 |
| 18 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.65077336 |
| 19 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.64132870 |
| 20 | FUS_26573619_Chip-Seq_HEK293_Human | 1.55530796 |
| 21 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.54465847 |
| 22 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.53426385 |
| 23 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.42311992 |
| 24 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.36025387 |
| 25 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.35668791 |
| 26 | P300_19829295_ChIP-Seq_ESCs_Human | 1.33140017 |
| 27 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.27914745 |
| 28 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.27240294 |
| 29 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.26819425 |
| 30 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.26676391 |
| 31 | STAT3_23295773_ChIP-Seq_U87_Human | 1.26194893 |
| 32 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.26024142 |
| 33 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.25720369 |
| 34 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.24374305 |
| 35 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.22285977 |
| 36 | AR_25329375_ChIP-Seq_VCAP_Human | 1.18512504 |
| 37 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.18189482 |
| 38 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.17441145 |
| 39 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.16264749 |
| 40 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.16090201 |
| 41 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.14038789 |
| 42 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.12523960 |
| 43 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.09100482 |
| 44 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.07202432 |
| 45 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.07177543 |
| 46 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03414049 |
| 47 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.02573007 |
| 48 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.02473442 |
| 49 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01875086 |
| 50 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.01222872 |
| 51 | EWS_26573619_Chip-Seq_HEK293_Human | 1.01103841 |
| 52 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.00431494 |
| 53 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.00283443 |
| 54 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99140557 |
| 55 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.98199601 |
| 56 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.97347526 |
| 57 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.97347526 |
| 58 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.96743714 |
| 59 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.96668201 |
| 60 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.93066506 |
| 61 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.92763376 |
| 62 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.92669747 |
| 63 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.92017142 |
| 64 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.91810076 |
| 65 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.90657080 |
| 66 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.90576057 |
| 67 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.89519513 |
| 68 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.89288141 |
| 69 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.88937084 |
| 70 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.88747152 |
| 71 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.88719931 |
| 72 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.86489509 |
| 73 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.83523491 |
| 74 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83237589 |
| 75 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.81316496 |
| 76 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.80237631 |
| 77 | TCF4_23295773_ChIP-Seq_U87_Human | 0.79512564 |
| 78 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.77936371 |
| 79 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.77709550 |
| 80 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.77709550 |
| 81 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.77622950 |
| 82 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.76743208 |
| 83 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.76245244 |
| 84 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.74233943 |
| 85 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.73625353 |
| 86 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.72316308 |
| 87 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.72316308 |
| 88 | POU3F1_26484290_ChIP-Seq_ESCss_Mouse | 0.71217065 |
| 89 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.71207768 |
| 90 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.70378689 |
| 91 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.69958476 |
| 92 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.69666492 |
| 93 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.68072546 |
| 94 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.67972404 |
| 95 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.67496272 |
| 96 | KDM2B_26808549_Chip-Seq_REH_Human | 0.67323259 |
| 97 | JUN_21703547_ChIP-Seq_K562_Human | 0.66824218 |
| 98 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.66616283 |
| 99 | GF1B_26923725_Chip-Seq_HPCs_Mouse | 0.65721157 |
| 100 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.65642747 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005171_absent_coat_pigmentation | 4.77043913 |
| 2 | MP0008872_abnormal_physiological_respon | 4.48372507 |
| 3 | MP0009764_decreased_sensitivity_to | 3.28971767 |
| 4 | MP0000372_irregular_coat_pigmentation | 3.13822413 |
| 5 | MP0005083_abnormal_biliary_tract | 2.91679618 |
| 6 | MP0002102_abnormal_ear_morphology | 2.75265769 |
| 7 | MP0009697_abnormal_copulation | 2.50112971 |
| 8 | MP0005503_abnormal_tendon_morphology | 2.22656864 |
| 9 | MP0003122_maternal_imprinting | 2.21226355 |
| 10 | MP0001984_abnormal_olfaction | 2.20382165 |
| 11 | MP0004859_abnormal_synaptic_plasticity | 2.17501066 |
| 12 | MP0002736_abnormal_nociception_after | 2.09633029 |
| 13 | MP0000778_abnormal_nervous_system | 2.03684614 |
| 14 | MP0000749_muscle_degeneration | 2.03096600 |
| 15 | MP0003221_abnormal_cardiomyocyte_apopto | 1.99831260 |
| 16 | MP0004270_analgesia | 1.92654288 |
| 17 | MP0006276_abnormal_autonomic_nervous | 1.86441977 |
| 18 | MP0003787_abnormal_imprinting | 1.84578785 |
| 19 | MP0002064_seizures | 1.79303725 |
| 20 | MP0005253_abnormal_eye_physiology | 1.77313693 |
| 21 | MP0003635_abnormal_synaptic_transmissio | 1.76631440 |
| 22 | MP0001968_abnormal_touch/_nociception | 1.75405552 |
| 23 | MP0002272_abnormal_nervous_system | 1.74625212 |
| 24 | MP0001529_abnormal_vocalization | 1.73432256 |
| 25 | MP0002735_abnormal_chemical_nociception | 1.69624531 |
| 26 | MP0003121_genomic_imprinting | 1.67608754 |
| 27 | MP0000569_abnormal_digit_pigmentation | 1.63290863 |
| 28 | MP0001502_abnormal_circadian_rhythm | 1.62372170 |
| 29 | MP0003880_abnormal_central_pattern | 1.61567537 |
| 30 | MP0005275_abnormal_skin_tensile | 1.58041515 |
| 31 | MP0002822_catalepsy | 1.53530564 |
| 32 | MP0004133_heterotaxia | 1.52843121 |
| 33 | MP0002733_abnormal_thermal_nociception | 1.52482258 |
| 34 | MP0005410_abnormal_fertilization | 1.51694104 |
| 35 | MP0006292_abnormal_olfactory_placode | 1.50083352 |
| 36 | MP0002734_abnormal_mechanical_nocicepti | 1.47833240 |
| 37 | MP0002876_abnormal_thyroid_physiology | 1.46330875 |
| 38 | MP0002638_abnormal_pupillary_reflex | 1.43759314 |
| 39 | MP0009745_abnormal_behavioral_response | 1.40431489 |
| 40 | MP0005084_abnormal_gallbladder_morpholo | 1.39795401 |
| 41 | MP0001970_abnormal_pain_threshold | 1.39173379 |
| 42 | MP0003195_calcinosis | 1.38628370 |
| 43 | MP0000747_muscle_weakness | 1.35200391 |
| 44 | MP0000631_abnormal_neuroendocrine_gland | 1.34026379 |
| 45 | MP0002163_abnormal_gland_morphology | 1.33767450 |
| 46 | MP0004811_abnormal_neuron_physiology | 1.33342883 |
| 47 | MP0009046_muscle_twitch | 1.32273812 |
| 48 | MP0005551_abnormal_eye_electrophysiolog | 1.30189459 |
| 49 | MP0003283_abnormal_digestive_organ | 1.28824039 |
| 50 | MP0004924_abnormal_behavior | 1.28451062 |
| 51 | MP0005386_behavior/neurological_phenoty | 1.28451062 |
| 52 | MP0006072_abnormal_retinal_apoptosis | 1.27545242 |
| 53 | MP0005423_abnormal_somatic_nervous | 1.24871535 |
| 54 | MP0002063_abnormal_learning/memory/cond | 1.24346597 |
| 55 | MP0002139_abnormal_hepatobiliary_system | 1.23396348 |
| 56 | MP0002653_abnormal_ependyma_morphology | 1.21240311 |
| 57 | MP0008770_decreased_survivor_rate | 1.20401032 |
| 58 | MP0008875_abnormal_xenobiotic_pharmacok | 1.19513302 |
| 59 | MP0010386_abnormal_urinary_bladder | 1.13364753 |
| 60 | MP0002909_abnormal_adrenal_gland | 1.11154412 |
| 61 | MP0002067_abnormal_sensory_capabilities | 1.11129748 |
| 62 | MP0002572_abnormal_emotion/affect_behav | 1.10806378 |
| 63 | MP0003011_delayed_dark_adaptation | 1.10759675 |
| 64 | MP0002837_dystrophic_cardiac_calcinosis | 1.09619924 |
| 65 | MP0003329_amyloid_beta_deposits | 1.08558177 |
| 66 | MP0004134_abnormal_chest_morphology | 1.07340503 |
| 67 | MP0002557_abnormal_social/conspecific_i | 1.06982486 |
| 68 | MP0009384_cardiac_valve_regurgitation | 1.05961792 |
| 69 | MP0002928_abnormal_bile_duct | 1.05422329 |
| 70 | MP0000371_diluted_coat_color | 1.02529068 |
| 71 | MP0002295_abnormal_pulmonary_circulatio | 1.00357955 |
| 72 | MP0001986_abnormal_taste_sensitivity | 1.00340677 |
| 73 | MP0002184_abnormal_innervation | 0.99512245 |
| 74 | MP0002882_abnormal_neuron_morphology | 0.99495839 |
| 75 | MP0000013_abnormal_adipose_tissue | 0.98301459 |
| 76 | MP0005379_endocrine/exocrine_gland_phen | 0.97859475 |
| 77 | MP0002269_muscular_atrophy | 0.96642309 |
| 78 | MP0001486_abnormal_startle_reflex | 0.95638242 |
| 79 | MP0002152_abnormal_brain_morphology | 0.94428159 |
| 80 | MP0000604_amyloidosis | 0.93920699 |
| 81 | MP0005645_abnormal_hypothalamus_physiol | 0.93890240 |
| 82 | MP0005195_abnormal_posterior_eye | 0.92721008 |
| 83 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.89793351 |
| 84 | MP0003252_abnormal_bile_duct | 0.89558814 |
| 85 | MP0001905_abnormal_dopamine_level | 0.86753728 |
| 86 | MP0000955_abnormal_spinal_cord | 0.86364850 |
| 87 | MP0002752_abnormal_somatic_nervous | 0.81654365 |
| 88 | MP0000427_abnormal_hair_cycle | 0.81207961 |
| 89 | MP0003634_abnormal_glial_cell | 0.78988245 |
| 90 | MP0001764_abnormal_homeostasis | 0.78594717 |
| 91 | MP0005085_abnormal_gallbladder_physiolo | 0.75245396 |
| 92 | MP0003633_abnormal_nervous_system | 0.73852974 |
| 93 | MP0003186_abnormal_redox_activity | 0.73306207 |
| 94 | MP0004142_abnormal_muscle_tone | 0.72593734 |
| 95 | MP0008877_abnormal_DNA_methylation | 0.70739619 |
| 96 | MP0003861_abnormal_nervous_system | 0.67106671 |
| 97 | MP0002229_neurodegeneration | 0.64738499 |
| 98 | MP0003183_abnormal_peptide_metabolism | 0.64164326 |
| 99 | MP0008438_abnormal_cutaneous_collagen | 0.63641448 |
| 100 | MP0010770_preweaning_lethality | 0.63542281 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oral leukoplakia (HP:0002745) | 7.99368575 |
| 2 | Cerebellar dysplasia (HP:0007033) | 6.85135606 |
| 3 | Type II lissencephaly (HP:0007260) | 6.62529422 |
| 4 | Calf muscle hypertrophy (HP:0008981) | 5.88431683 |
| 5 | Anomalous pulmonary venous return (HP:0010772) | 5.69796085 |
| 6 | Hemiplegia (HP:0002301) | 5.43658200 |
| 7 | Abnormality of the pulmonary veins (HP:0011718) | 5.21716606 |
| 8 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.08557438 |
| 9 | Hypoplasia of the pons (HP:0012110) | 4.89647191 |
| 10 | Abnormality of the pons (HP:0007361) | 4.61631692 |
| 11 | Hypothermia (HP:0002045) | 4.28510994 |
| 12 | Shoulder girdle muscle weakness (HP:0003547) | 3.94172564 |
| 13 | Limb-girdle muscle atrophy (HP:0003797) | 3.91951301 |
| 14 | Pelvic girdle muscle weakness (HP:0003749) | 3.85479526 |
| 15 | Abnormality of the musculature of the pelvis (HP:0001469) | 3.77508596 |
| 16 | Abnormality of the hip-girdle musculature (HP:0001445) | 3.77508596 |
| 17 | Frequent falls (HP:0002359) | 3.66642158 |
| 18 | Delayed gross motor development (HP:0002194) | 3.54131694 |
| 19 | Vertebral fusion (HP:0002948) | 3.53608376 |
| 20 | Death in childhood (HP:0003819) | 3.42941048 |
| 21 | Short femoral neck (HP:0100864) | 3.28816522 |
| 22 | Lissencephaly (HP:0001339) | 3.22347427 |
| 23 | Achilles tendon contracture (HP:0001771) | 3.15236140 |
| 24 | Drooling (HP:0002307) | 3.09562281 |
| 25 | Hemivertebrae (HP:0002937) | 3.07034517 |
| 26 | Severe muscular hypotonia (HP:0006829) | 3.06381071 |
| 27 | Abnormality of the Achilles tendon (HP:0005109) | 3.03829549 |
| 28 | Meningocele (HP:0002435) | 3.02888157 |
| 29 | Lipid accumulation in hepatocytes (HP:0006561) | 3.00611737 |
| 30 | Neoplasm of the heart (HP:0100544) | 2.95708829 |
| 31 | Difficulty climbing stairs (HP:0003551) | 2.95559311 |
| 32 | Short 4th metacarpal (HP:0010044) | 2.92216570 |
| 33 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.92216570 |
| 34 | Rough bone trabeculation (HP:0100670) | 2.85413036 |
| 35 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.83986365 |
| 36 | Spinal muscular atrophy (HP:0007269) | 2.82269480 |
| 37 | Excessive salivation (HP:0003781) | 2.81902708 |
| 38 | Hypoplasia of the brainstem (HP:0002365) | 2.79968542 |
| 39 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.79968542 |
| 40 | Pachygyria (HP:0001302) | 2.77644220 |
| 41 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.75415683 |
| 42 | Hyperventilation (HP:0002883) | 2.65667249 |
| 43 | Leukodystrophy (HP:0002415) | 2.61506349 |
| 44 | Increased hepatocellular lipid droplets (HP:0006565) | 2.54608465 |
| 45 | Upper motor neuron abnormality (HP:0002127) | 2.54228220 |
| 46 | Amelogenesis imperfecta (HP:0000705) | 2.53654789 |
| 47 | Premature graying of hair (HP:0002216) | 2.47421314 |
| 48 | Focal motor seizures (HP:0011153) | 2.47318816 |
| 49 | Hypoventilation (HP:0002791) | 2.40947694 |
| 50 | Abnormality of the odontoid process (HP:0003310) | 2.40325752 |
| 51 | Broad ribs (HP:0000885) | 2.34197809 |
| 52 | Abnormality of the intervertebral disk (HP:0005108) | 2.33762515 |
| 53 | Deformed sella turcica (HP:0002681) | 2.26137973 |
| 54 | Abnormality of the calf musculature (HP:0001430) | 2.23154744 |
| 55 | Hepatocellular necrosis (HP:0001404) | 2.22271732 |
| 56 | Myoglobinuria (HP:0002913) | 2.20285594 |
| 57 | Pathologic fracture (HP:0002756) | 2.19707718 |
| 58 | Redundant skin (HP:0001582) | 2.13052670 |
| 59 | Abnormality of the 4th metacarpal (HP:0010012) | 2.12596204 |
| 60 | Mitochondrial inheritance (HP:0001427) | 2.09964495 |
| 61 | Macroglossia (HP:0000158) | 2.08958676 |
| 62 | Medulloblastoma (HP:0002885) | 2.07882245 |
| 63 | Postural tremor (HP:0002174) | 2.06741640 |
| 64 | Aplasia/hypoplasia of the femur (HP:0005613) | 2.06535785 |
| 65 | Arterial tortuosity (HP:0005116) | 2.05734299 |
| 66 | Abnormal trabecular bone morphology (HP:0100671) | 2.03920339 |
| 67 | Myelomeningocele (HP:0002475) | 2.03630100 |
| 68 | Pancreatic cysts (HP:0001737) | 2.00254895 |
| 69 | Proximal amyotrophy (HP:0007126) | 1.97409858 |
| 70 | Down-sloping shoulders (HP:0200021) | 1.96680153 |
| 71 | Increased CSF lactate (HP:0002490) | 1.96238964 |
| 72 | CNS hypomyelination (HP:0003429) | 1.95208850 |
| 73 | Abnormality of the renal cortex (HP:0011035) | 1.94706296 |
| 74 | Cellular immunodeficiency (HP:0005374) | 1.94375381 |
| 75 | Neoplasm of the oral cavity (HP:0100649) | 1.93101333 |
| 76 | Renal Fanconi syndrome (HP:0001994) | 1.92275718 |
| 77 | Nephronophthisis (HP:0000090) | 1.90808697 |
| 78 | Vascular tortuosity (HP:0004948) | 1.87910549 |
| 79 | Hepatic necrosis (HP:0002605) | 1.87560219 |
| 80 | Hyperglycinemia (HP:0002154) | 1.87158586 |
| 81 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 1.86471614 |
| 82 | Posterior subcapsular cataract (HP:0007787) | 1.85470232 |
| 83 | Pendular nystagmus (HP:0012043) | 1.84919110 |
| 84 | Abnormality of the vitreous humor (HP:0004327) | 1.81087098 |
| 85 | Late onset (HP:0003584) | 1.79891003 |
| 86 | Agitation (HP:0000713) | 1.79737584 |
| 87 | Intellectual disability, profound (HP:0002187) | 1.79466042 |
| 88 | Glycosuria (HP:0003076) | 1.78904648 |
| 89 | Abnormality of urine glucose concentration (HP:0011016) | 1.78904648 |
| 90 | Abnormality of midbrain morphology (HP:0002418) | 1.73487278 |
| 91 | Molar tooth sign on MRI (HP:0002419) | 1.73487278 |
| 92 | Vertebral arch anomaly (HP:0008438) | 1.67114480 |
| 93 | Limb-girdle muscle weakness (HP:0003325) | 1.66912717 |
| 94 | Broad-based gait (HP:0002136) | 1.66656497 |
| 95 | Carpal bone hypoplasia (HP:0001498) | 1.62410035 |
| 96 | Prominent occiput (HP:0000269) | 1.60426180 |
| 97 | Focal seizures (HP:0007359) | 1.59083631 |
| 98 | Oligodontia (HP:0000677) | 1.59042789 |
| 99 | Abnormality of salivation (HP:0100755) | 1.58543154 |
| 100 | Increased corneal curvature (HP:0100692) | 1.58018227 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K4 | 8.34167630 |
| 2 | MAP2K7 | 8.04057261 |
| 3 | MAP2K4 | 4.97246992 |
| 4 | ZAK | 4.42430817 |
| 5 | TLK1 | 3.77698638 |
| 6 | EPHA3 | 2.50510691 |
| 7 | CASK | 2.49457054 |
| 8 | BLK | 2.12508097 |
| 9 | VRK1 | 2.11378295 |
| 10 | MARK1 | 1.79709647 |
| 11 | MAP4K2 | 1.71121865 |
| 12 | RET | 1.62924807 |
| 13 | ADRBK2 | 1.58479939 |
| 14 | FRK | 1.48865204 |
| 15 | MAPK13 | 1.38895382 |
| 16 | PDK2 | 1.09181241 |
| 17 | PKN1 | 1.07809215 |
| 18 | CSNK1G2 | 1.07573939 |
| 19 | LATS1 | 1.06261360 |
| 20 | PRKCI | 1.03854924 |
| 21 | EEF2K | 0.92346845 |
| 22 | NTRK3 | 0.92160444 |
| 23 | CSNK1G3 | 0.90734794 |
| 24 | ERBB3 | 0.90734574 |
| 25 | NUAK1 | 0.89918956 |
| 26 | CSNK1A1L | 0.89481100 |
| 27 | CSNK1G1 | 0.89130395 |
| 28 | TNIK | 0.87281618 |
| 29 | RPS6KA5 | 0.87074358 |
| 30 | NTRK2 | 0.83994492 |
| 31 | MAPKAPK3 | 0.81100766 |
| 32 | GRK1 | 0.76542986 |
| 33 | PTK2B | 0.75546681 |
| 34 | PRKCH | 0.70378825 |
| 35 | DYRK2 | 0.69917010 |
| 36 | EIF2AK3 | 0.66706176 |
| 37 | TAF1 | 0.64455707 |
| 38 | WNK3 | 0.63755395 |
| 39 | PRKCG | 0.63437830 |
| 40 | BMPR1B | 0.61552651 |
| 41 | DAPK3 | 0.61431610 |
| 42 | STK4 | 0.60155861 |
| 43 | PRKAA1 | 0.59035991 |
| 44 | MAP2K6 | 0.57009059 |
| 45 | TRIM28 | 0.56886669 |
| 46 | PLK2 | 0.56594222 |
| 47 | AURKA | 0.54009316 |
| 48 | PAK3 | 0.53106935 |
| 49 | PRKCE | 0.52017086 |
| 50 | CAMKK2 | 0.51801751 |
| 51 | PINK1 | 0.50819675 |
| 52 | TAOK3 | 0.48871940 |
| 53 | BRSK2 | 0.47451474 |
| 54 | PAK6 | 0.47224468 |
| 55 | BCR | 0.46145651 |
| 56 | SIK2 | 0.45989477 |
| 57 | PHKG2 | 0.43687482 |
| 58 | PHKG1 | 0.43687482 |
| 59 | DAPK2 | 0.43077565 |
| 60 | LMTK2 | 0.38569871 |
| 61 | PIM1 | 0.34783068 |
| 62 | PRKCQ | 0.34243972 |
| 63 | CCNB1 | 0.31064500 |
| 64 | BRSK1 | 0.30822897 |
| 65 | ADRBK1 | 0.30797295 |
| 66 | MAPK11 | 0.29277691 |
| 67 | MAPKAPK5 | 0.27745306 |
| 68 | PRKCZ | 0.27477968 |
| 69 | GRK5 | 0.25857682 |
| 70 | ACVR1B | 0.23049272 |
| 71 | SGK2 | 0.21566551 |
| 72 | LATS2 | 0.20676400 |
| 73 | STK39 | 0.19690242 |
| 74 | CAMK4 | 0.18933332 |
| 75 | SGK494 | 0.17860469 |
| 76 | SGK223 | 0.17860469 |
| 77 | NEK6 | 0.17455989 |
| 78 | NTRK1 | 0.17409044 |
| 79 | CHEK2 | 0.16966613 |
| 80 | MKNK2 | 0.16525657 |
| 81 | FER | 0.16342661 |
| 82 | WNK4 | 0.14599124 |
| 83 | MAP2K3 | 0.14533801 |
| 84 | HIPK2 | 0.14138738 |
| 85 | ROCK1 | 0.13366179 |
| 86 | CAMK2A | 0.13239790 |
| 87 | DYRK1A | 0.12332583 |
| 88 | CDK5 | 0.11479004 |
| 89 | TRPM7 | 0.10995217 |
| 90 | STK38L | 0.10974507 |
| 91 | CAMK1D | 0.10226442 |
| 92 | PRKACA | 0.10017295 |
| 93 | CSNK1A1 | 0.09659715 |
| 94 | CSNK1D | 0.09438162 |
| 95 | BUB1 | 0.09188969 |
| 96 | MAPK12 | 0.09014477 |
| 97 | ATR | 0.08297409 |
| 98 | PRKCA | 0.07354533 |
| 99 | MAPK9 | 0.07296782 |
| 100 | PLK1 | 0.06648653 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 6.33894589 |
| 2 | Alcoholism_Homo sapiens_hsa05034 | 4.99715886 |
| 3 | Selenocompound metabolism_Homo sapiens_hsa00450 | 3.13308031 |
| 4 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 2.38437286 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.23885461 |
| 6 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.98476612 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.96858433 |
| 8 | Insulin secretion_Homo sapiens_hsa04911 | 1.87728626 |
| 9 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.79216444 |
| 10 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.74831162 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.72572295 |
| 12 | Nicotine addiction_Homo sapiens_hsa05033 | 1.70386886 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.58370165 |
| 14 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.56018198 |
| 15 | Morphine addiction_Homo sapiens_hsa05032 | 1.49733697 |
| 16 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.49684096 |
| 17 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.44104671 |
| 18 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.42058059 |
| 19 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.38225944 |
| 20 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.37134931 |
| 21 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.29146890 |
| 22 | RNA polymerase_Homo sapiens_hsa03020 | 1.27267375 |
| 23 | Phototransduction_Homo sapiens_hsa04744 | 1.23208215 |
| 24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.22761871 |
| 25 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.22049451 |
| 26 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.21874867 |
| 27 | Circadian entrainment_Homo sapiens_hsa04713 | 1.20445592 |
| 28 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.15349921 |
| 29 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.12440073 |
| 30 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.10090589 |
| 31 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.08383440 |
| 32 | GABAergic synapse_Homo sapiens_hsa04727 | 1.06950342 |
| 33 | Salivary secretion_Homo sapiens_hsa04970 | 1.06288541 |
| 34 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.02547561 |
| 35 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.01635638 |
| 36 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.98680350 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.96486054 |
| 38 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.94555947 |
| 39 | Colorectal cancer_Homo sapiens_hsa05210 | 0.93055264 |
| 40 | Olfactory transduction_Homo sapiens_hsa04740 | 0.89457562 |
| 41 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.87139579 |
| 42 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.85087747 |
| 43 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.82910008 |
| 44 | Histidine metabolism_Homo sapiens_hsa00340 | 0.81376604 |
| 45 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.81169772 |
| 46 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.79767563 |
| 47 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.79525783 |
| 48 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.79350736 |
| 49 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.78955207 |
| 50 | Renin secretion_Homo sapiens_hsa04924 | 0.78716477 |
| 51 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.75881823 |
| 52 | Gap junction_Homo sapiens_hsa04540 | 0.75282147 |
| 53 | Parkinsons disease_Homo sapiens_hsa05012 | 0.75236705 |
| 54 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.74396626 |
| 55 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.73399997 |
| 56 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.73167175 |
| 57 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.72329021 |
| 58 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.71200810 |
| 59 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.69200173 |
| 60 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.68146623 |
| 61 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.67065188 |
| 62 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.64532516 |
| 63 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.64480632 |
| 64 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.64214874 |
| 65 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.63873736 |
| 66 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.62805518 |
| 67 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.60977148 |
| 68 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.60023580 |
| 69 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.59572152 |
| 70 | Peroxisome_Homo sapiens_hsa04146 | 0.57029481 |
| 71 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.56116571 |
| 72 | Cocaine addiction_Homo sapiens_hsa05030 | 0.55027633 |
| 73 | ABC transporters_Homo sapiens_hsa02010 | 0.54995623 |
| 74 | Axon guidance_Homo sapiens_hsa04360 | 0.54728440 |
| 75 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.54504221 |
| 76 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.54405634 |
| 77 | Alzheimers disease_Homo sapiens_hsa05010 | 0.53241342 |
| 78 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.52279353 |
| 79 | Homologous recombination_Homo sapiens_hsa03440 | 0.51927201 |
| 80 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.51595402 |
| 81 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.50751751 |
| 82 | Lysosome_Homo sapiens_hsa04142 | 0.49343192 |
| 83 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.47703979 |
| 84 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.46932345 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46293152 |
| 86 | Huntingtons disease_Homo sapiens_hsa05016 | 0.44700011 |
| 87 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.43859428 |
| 88 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.41250639 |
| 89 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.41115235 |
| 90 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.41058786 |
| 91 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.40492106 |
| 92 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.40426345 |
| 93 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.40387021 |
| 94 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.40268128 |
| 95 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.38917454 |
| 96 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.37284671 |
| 97 | Basal transcription factors_Homo sapiens_hsa03022 | 0.31834003 |
| 98 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.31629232 |
| 99 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.31508313 |
| 100 | Taste transduction_Homo sapiens_hsa04742 | 0.29915117 |

